The short answer
Chromium supplements may add to glucose-lowering treatment, so caution with metformin is reasonable. However, studies do not establish how often chromium plus metformin alone causes hypoglycemia. Chromium trial results are mixed, and a possible interaction should not be presented as a proven frequent event.
What this answer covers
Oral nutritional chromium supplements, mainly chromium picolinate in the cited trials; not industrial hexavalent chromium exposure.
- Supplement or preparation
- Chromium
- Medication ingredient
- metformin
Why does the warning exist?
The NIH Office of Dietary Supplements notes that chromium might lower glucose and therefore might add to the effects of metformin or other diabetes medicines. This is a precaution based on possible overlapping effects. It is useful for reviewing a medication list, but it does not provide a measured event rate for people taking only metformin and chromium.
What do the clinical trials show?
A 71-person trial reported improved glucose measures with a chromium picolinate regimen over four months. Another trial in 137 adults found no significant overall difference in fasting glucose or HbA1c with 1,000 micrograms of chromium daily for 24 weeks, although selected responders improved. Neither establishes an isolated metformin-related hypoglycemia rate.
What should be checked on my list?
Keep the chromium salt, amount and other ingredients visible. Risk also depends on whether you use insulin or a sulfonylurea, because those medicines can cause low glucose independently. Metformin alone rarely does so. A study involving several diabetes medicines cannot tell you which component caused an event or predict the response to a different supplement blend.
Should I take chromium at another time?
No clinical interval in the checked evidence is proven to prevent a glucose-lowering effect. Discuss the reason for taking chromium and a suitable monitoring plan with the clinician managing your diabetes. Do not use uncertain supplement benefits as a reason to change metformin or other prescribed doses on your own.
Evidence and practical considerations
Side effects & toxicity
Chromium supplements may add to glucose-lowering treatment, so caution with metformin is reasonable. However, studies do not establish how often chromium plus metformin alone causes hypoglycemia. Chromium trial results are mixed, and a possible interaction should not be presented as a proven frequent event.
- Exact scope
- oral chromium supplements with salt and elemental amount recorded with oral metformin; hydrochloride IR, ER or low-dose solution retained source by source
- Medication form and route
- oral
- Timing or duration
- Trials lasted four months or 24 weeks; no validated protective hourly interval.
What remains uncertain
- Institutional precaution and mixed chromium trials do not quantify exact metformin-only hypoglycemia risk.
Factors that may matter: exact preparation and dose; medication formulation and duration; other medicines and underlying conditions; source population and measured outcome.
Read the supporting source summaries
Source 1: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults receiving oral extended-release metformin hydrochloride.
Advises annual hematologic assessment and B12 measurements every 2-3 years. Hypoglycemia is uncommon with metformin alone but risk is greater with insulin or secretagogues and other circumstances.
How this applies: Exact metformin parent RxCUI 6809 with hydrochloride formulation retained. Monitoring and general precautions only unless B12 is the counterparty. Counterparty scope for this package: oral chromium supplements with salt and elemental amount recorded.
Extended-release label is not a study of immediate-release interaction kinetics; no aloe, chromium or goldenseal-specific effect or interval quantified.
Source 2: authoritative institutional evidence summary
ods.od.nih.gov · Source check Sep 10, 2026
Population: People taking chromium supplements and glucose-lowering medicines.
Warns of a possible additive glucose-lowering effect with metformin; describes mixed clinical trial results.
How this applies: Explicit metformin warning supports a precaution while direct risk remains unquantified. Counterparty scope for this package: oral chromium supplements with salt and elemental amount recorded.
The metformin warning is an inference from chromium effects, not a reported exact-pair event-rate trial. Original trial evidence is separately retained.
Source 3: original randomized controlled trial
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 137 adults with type 2 diabetes, 70 chromium and 67 placebo.
Overall insulin sensitivity, fasting glucose and HbA1c did not differ significantly; post hoc responder subgroups improved.
How this applies: Chromium glycemic-effect context only, indirect to exact metformin interaction. Counterparty scope for this package: oral chromium supplements with salt and elemental amount recorded.
No isolated metformin coadministration result or hypoglycemia-risk comparison established. Responder selection cannot establish a universal effect.
Source 4: original randomized controlled trial
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 71 adults with poorly controlled type 2 diabetes, 32 supplemented and 39 controls.
Greater fasting/post-meal glucose and HbA1c improvement in supplemented group.
How this applies: Supports possible glucose effects from a specific chromium preparation, not a quantified metformin-only safety outcome. Counterparty scope for this package: oral chromium supplements with salt and elemental amount recorded.
Abstract does not identify an isolated metformin subgroup or report hypoglycemia events; single-blind design. Exact reporting of elemental chromium versus complex mass not clarified in abstract.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original evidence and current labels checked; complete private article and exact-current-claim adjudications prepared. | |
| Research summary published |
Article revision: c5eda8d4ff830600
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.